These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8595203

  • 1. Neuroprotective effects of NBQX on hypoxia-induced neuronal damage in rat hippocampus.
    Matsuoka Y, Kitamura Y, Tsukahara T, Terai K, Tooyama I, Kimura H, Taniguchi T.
    Neuroreport; 1995 Nov 13; 6(16):2205-8. PubMed ID: 8595203
    [Abstract] [Full Text] [Related]

  • 2. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P, Diemer NH, Bruhn T, Johansen FF.
    J Cereb Blood Flow Metab; 1997 Feb 13; 17(2):147-52. PubMed ID: 9040493
    [Abstract] [Full Text] [Related]

  • 3. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
    Prehn JH, Lippert K, Krieglstein J.
    Eur J Pharmacol; 1995 Jan 13; 292(2):179-89. PubMed ID: 7720791
    [Abstract] [Full Text] [Related]

  • 4. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, Hatanaka K, Ohmori J, Koshiya K, Usuda S, Murase K.
    J Pharmacol Exp Ther; 1996 Jan 13; 276(1):84-92. PubMed ID: 8558460
    [Abstract] [Full Text] [Related]

  • 5. In vivo hypoxia-induced neuronal damage in dentate gyrus of rat hippocampus: changes in NMDA receptors and the effect of MK-801.
    Matsuoka Y, Kitamura Y, Fukunaga R, Shimohama S, Nabeshima T, Tooyama I, Kimura H, Taniguchi T.
    Neurochem Int; 1997 Jun 13; 30(6):533-42. PubMed ID: 9152994
    [Abstract] [Full Text] [Related]

  • 6. NBQX prevents contralateral but not ipsilateral seizure-induced cytotoxicity of kainate but not AMPA-reversal at high doses of NBQX.
    Lees GJ, Leong W.
    Neuroreport; 1994 Oct 27; 5(16):2153-6. PubMed ID: 7532455
    [Abstract] [Full Text] [Related]

  • 7. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist.
    Kohara A, Okada M, Tsutsumi R, Ohno K, Takahashi M, Shimizu-Sasamata M, Shishikura J, Inami H, Sakamoto S, Yamaguchi T.
    J Pharm Pharmacol; 1998 Jul 27; 50(7):795-801. PubMed ID: 9720630
    [Abstract] [Full Text] [Related]

  • 8. NMDA and non-NMDA receptor gene expression following global brain ischemia in rats: effect of NMDA and non-NMDA receptor antagonists.
    Pellegrini-Giampietro DE, Pulsinelli WA, Zukin RS.
    J Neurochem; 1994 Mar 27; 62(3):1067-73. PubMed ID: 8113793
    [Abstract] [Full Text] [Related]

  • 9. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR, Teng YD, Marriott R.
    Exp Neurol; 1997 Jun 27; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury.
    Koh S, Tibayan FD, Simpson JN, Jensen FE.
    Epilepsia; 2004 Jun 27; 45(6):569-75. PubMed ID: 15144420
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
    Montero M, Nielsen M, Rønn LC, Møller A, Noraberg J, Zimmer J.
    Brain Res; 2007 Oct 26; 1177():124-35. PubMed ID: 17894933
    [Abstract] [Full Text] [Related]

  • 13. LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia.
    O'Neill MJ, Bogaert L, Hicks CA, Bond A, Ward MA, Ebinger G, Ornstein PL, Michotte Y, Lodge D.
    Neuropharmacology; 2000 Jul 10; 39(9):1575-88. PubMed ID: 10854902
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
    Moncada C, Arvin B, Le Peillet E, Meldrum BS.
    Neurosci Lett; 1991 Dec 09; 133(2):287-90. PubMed ID: 1816508
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Over-additive protective effect of dizocilpine and NBQX against neuronal damage.
    Lippert K, Welsch M, Krieglstein J.
    Eur J Pharmacol; 1994 Mar 03; 253(3):207-13. PubMed ID: 7911083
    [Abstract] [Full Text] [Related]

  • 19. It is AMPA receptor, not kainate receptor, that contributes to the NBQX-induced antinociception in the spinal cord of rats.
    Kong LL, Yu LC.
    Brain Res; 2006 Jul 19; 1100(1):73-7. PubMed ID: 16777075
    [Abstract] [Full Text] [Related]

  • 20. NMDA and AMPA/kainate glutamate receptors modulate dentate neurogenesis and CA3 synapsin-I in normal and ischemic hippocampus.
    Bernabeu R, Sharp FR.
    J Cereb Blood Flow Metab; 2000 Dec 19; 20(12):1669-80. PubMed ID: 11129783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.